medical device guru

Diagnostics & Healthcare News
Boston Scientific to Acquire BTG for $4.2 Billion
Boston Scientific today announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc., a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases,...
November 20, 2018
Diagnostics & Healthcare News
Boston Scientific to Restructure, Expects $200M in Cut Costs
Boston Scientific said yesterday that it’s planning a three-year restructuring program that’s slated to cost at least $200 million. The Marlborough, Mass.-based medical device maker said it expects to maintain roughly the same number of workers, although there will be...
November 16, 2018
Diagnostics & Healthcare News
FDA Approves Implantable Glucose Monitor Insertion/Removal by Non-Physicians
Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today has announced that the Eversense® Continuous Glucose Monitoring (CGM) System has received FDA approval...
November 7, 2018
Diagnostics & Healthcare News
In-Home Fertility Tracking System Wins CE Mark
Concepta plc, the innovative UK healthcare company and developer of the proprietary self-test platform (“myLotus”) and suite of emerging test products targeting the mobile health market is pleased to announce it has received CE-Mark certification for its myLotus branded products for...
November 1, 2018
Diagnostics & Healthcare News
Medical Rep Rebuked by FDA for Misleading Statements during Doctor’s Lunch
The latest admonishment from the FDA’s promo police is an unusual one. In it, the agency scolds an Eisai sales rep accused of misleading healthcare professionals during a presentation on antiseizure drug Fycompa. What’s different about the FDA’s latest untitled...
October 30, 2018
Diagnostics & Healthcare News
Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA
In an extraordinary step forward for the psychedelic drug research community, the US Food and Drug Administration (FDA) has just given psilocybin therapy for treatment-resistant depression a Breakthrough Therapy designation. This classification suggests the treatment has demonstrated significant potential in...
October 25, 2018
Diagnostics & Healthcare News
First US Clinical Trial using Focused Ultrasound for Alzheimer’s Disease Underway
Researchers at the West Virginia University (WVU) Rockefeller Neuroscience Institute have treated the first patient in a new, groundbreaking clinical trial utilizing focused ultrasound to open the blood-brain barrier (BBB) in patients with early Alzheimer’s disease. Led by neurosurgeon Ali Rezai, MD,...
October 23, 2018
Diagnostics & Healthcare News
Apple and Zimmer Biomet team up to use Apple Watch to improve knee and hip surgery recovery process
As Apple pushes deeper into health care with the Apple Watch, the company is developing a plan to help people who are recovering from knee and hip replacement surgeries. On Monday, Apple announced a partnership with medical device company Zimmer Biomet, to combine...
October 19, 2018
Diagnostics & Healthcare News
Merit Medical to acquire Cianna Medical for up to $200M
Merit Medical said this week that it agreed to acquire Cianna Medical and its breast cancer localization and guidance devices for up to $200 million. Aliso Viejo, Calif.-based Cianna makes the Savi Scout wire-free breast tumor localization system, designed to produce audible and visual...
October 5, 2018
1 2 3 4 22